The -308 G/A tumor necrosis factor-α gene dimorphism: A risk factor for unstable angina

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 4, 2003, Pages 511-516

  Bernard, Virginie ^a   Pillois, Xavier ^a   Dubus, Isabelle ^a,b   Benchimol, Daniel ^a   Labouyrie, Jean Pierre ^b   Couffinhal, Thierry ^a   Coste, Pierre ^a   Bonnet, Jacques ^a  

^a Inst National la Sante Rech Med   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Acute coronary syndrome; Body mass index; Gene polymorphism; Tumor necrosis factor ; Unstable angina

Indexed keywords

ADENOSINE; CYTOKINE; GUANINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY MASS; CLINICAL OBSERVATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; GENE CONTROL; GENE FREQUENCY; GENE FUNCTION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HETEROZYGOTE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; STABLE ANGINA PECTORIS; STATISTICAL ANALYSIS; UNSTABLE ANGINA PECTORIS;

AGED; ALLELES; ANGINA PECTORIS; ANGINA, UNSTABLE; BODY MASS INDEX; CORONARY ARTERIOSCLEROSIS; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

ANGINA;

EID: 0037721389     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.077     Document Type: Article

References (45)

1. DeGraba TJ. Expression of inflammatory mediators and adhesion molecules in human atherosclerotic plaque. Neurology 1997; 49(5 Suppl 4):S15-9.
2. Maseri A. Inflammation, atherosclerosis, and ischemic events - exploring the hidden side of the moon. N Engl J Med 1997; 336:1014-6.
3. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138(5 Pt 2):S419-20.
4. Zaman AG, Helft G, Worthley SG, Badimon JJ. The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis 2000; 149:251-66.
5. de Jong AL, Green DM, Trial JA, Birdsall HH. Focal effects of mononuclear leukocyte transenclothelial migration: TNF-alpha production by migrating monocytes promotes subsequent migration of lymphocytes. J Leukoc Biol 1996; 60:129-36.
6. Mauviel A. Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 1993;53:288-95.
7. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 1994; 75:181-9.
8. Hirsch GM, Kearsey J, Burt T, Karnovsky MJ, Lee T. Medial smooth muscle cell loss in arterial allografts occurs by cytolytic cell induced apoptosis. Eur J Cardiothorac Surg 1998; 14:89-97.
9. Napoli C, Quehenberger O, De Nigris F, Abete P, Glass CK, Palinski W. Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells. FASEB J 2000; 14:1996-2007.
10. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 1990; 65:297-302.
11. Arbustini E, Grasso M, Diegoli M, Pucci A, Bramerio M, Ardissino D, et al. Coronary atherosclerotic plaques with and without thrombus in ischemic heart syndromes: a morphologic, immunohistochemical, and biochemical study. Am J Cardiol 1991; 68:36B-50B.
12. Rayment NB, Moss E, Faulkner L, Brickell PM, Davies MJ, Woolf N, et al. Synthesis of TNF alpha and TGF beta mRNA in the different micro-environments within atheromatous plaques. Cardiovasc Res 1996; 32:1123-30.
13. Kaartinen M, Penttila A, Kovanen PT. Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. Circulation 1996; 94:2787-92.
14. Kaartinen M, van der Wal AC, van der Loos CM, Piek JJ, Koch KT, Becker AE, et al. Mast cell infiltration in acute coronary syndromes: implications for plaque rupture. J Am Coll Cardiol 1998; 32:606-12.
15. Basaran Y, Basaran MM, Babacan KF, Ener B, Okay T, Gok H, et al. Serum tumor necrosis factor levels in acute myocardial infarction and unstable angina pectoris. Angiology 1993; 44:332-7.
16. Vaddi K, Nicolini FA, Mehta P, Mehta JL. Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation. Circulation 1994; 90:694-9.
17. Porsch-Oezcueruemez M, Kunz D, Kloer HU, Luley C. Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease. J Am Coll Cardiol 1999; 34:1995-2001.
18. Bruunsgaard H, Skinhoj P, Pedersen AN, Schroll M, Pedersen BK. Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clin Exp Immunol 2000; 121:255-60.
19. Glass CK, Witztum JL. Atherosclerosis. the road ahead. Cell 2001;104:503-16.
20. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990; 87:1233-7.
21. Abraham LJ, French MA, Dawkins RL. Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol 1993; 92:14-8.
22. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94:3195-9.
23. Kroeger KM, Abraham LJ. Identification of an AP-2 element in the -323 to -285 region of the TNF-alpha gene. Biochem Mol Biol Int 1996; 40:43-51.
24. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-La-fontaine N, Roland S, et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113:401-6.
25. Abraham LJ, Kroeger KM. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 1999; 66:562-6.
26. Wilson A, di Giovine F, Blakemore A, Duff G. Single base change in the human tumor necrosis factor alpha (TNF-α) gene detectable by Ncol restriction of PCR product. Human Mol Genet 1992; 1:353.
27. Paul S, Donner A. A comparison of tests of homogeneity of odds ratios in k 2 × 2 tables. Stat Med 1989; 8:1455-68.
28. Gart J. Alternative analyses of contingency tables. J R Stat Assoc 1966; 28:164-9.
29. Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A, et al. Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest 1998; 28:59-66.
30. Collins JS, Perry RT, Watson B Jr, Harrell LE, Acton RT, Blacker D, et al. Association of a haplotype for tumor necrosis factor in siblings with late-onset alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative. Am J Med Genet 2000; 96:823-30.
31. Louis E, Peeters M, Franchimont D, Seidel L, Fontaine F, Demolin G, et al. Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour? Clin Exp Immunol 2000; 119:64-8.
32. Carlsen SM, Waage A, Grill V, Folling I. Metformin increases circulating tumour necrosis factor-alpha levels in non-obese non-diabetic patients with coronary heart disease. Cytokine 1998; 10:66-9.
33. Halle M, Berg A, Northoff H, Keul J. Importance of TNF-alpha and leptin in obesity and insulin resistance: a hypothesis on the impact of physical exercise. Exerc Immunol Rev 1998; 4:77-94.
34. Padovani JC, Pazin-Filho A, Simoes MV, Marin-Neto JA, Zago MA, Franco RF. Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb Res 2000; 100:263-9.
35. Brand E, Schorr U, Kunz I, Kertmen E, Ringel J, Distler A, et al. Tumor necrosis factor-alpha-308 G/A polymorphism in obese Caucasians. Int J Obes Relat Metab Disord 2001; 25:581-5.
36. Daley GQ, Cargill M. The heart SNPs a beat: polymorphisms in candidate genes for cardiovascular disease. Trends Cardiovasc Med 2001; 11:60-6.
37. Kubota T, McNamara DM, Wang JJ, Trost M, McTiernan CF, Mann DL, et al. Effects of tumor necrosis factor gene polymophisms on patients with congestive heart failure. VEST Investigators for TNF Genotype Analysis. Vesnarinone Survival Trial. Circulation 1998; 97:2499-501.
38. Keso T, Perola M, Laippala P, Ilveskoski E, Kunnas TA, Mikkelsson J, et al. Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis 2001; 154: 691-7.
39. Wang XL, Oosterhof J. Tumour necrosis factor alpha G-308-A polymorphism and risk for coronary artery disease. Clin Sci (Colch) 2000; 98:435-7.
40. Koch W, Kastrati A, Bottiger C, Mehilli J, von Beckerath N, Schomig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 2001; 159:137-44.
41. Topol EJ, Van de Werf FJ. Acute myocardial infarction. Early diagnosis and management. In: Topol EJ, editor. Textbook of cardiovascular medicine. Philadelphia: Lippincott-Raven; 1998:395-435.
42. Ott I, Andrassy M, Zieglgansberger D, Geith S, Schomig A, Neumann FJ. Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1. Blood 2001; 97:3721-6.
43. Ardissino D, Mannucci PM, Merlini PA, Duca F, Fetiveau R, Tagliabue L, et al. Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood 1999; 94: 46-51.
44. Webb KE, Martin JF, Hamsten A, Eriksson P, Iacoviello L, Gattone M, et al. Polymorphisms in the thrombopoietin gene are associated with risk of myocardial infarction at a young age. Atherosclerosis 2001; 154:703-11.
45. Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, Carter ND, et al. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 1999; 99:861-6.